AbbVie rStock

RABBV

AbbVie Inc. is a research-driven global biopharmaceutical powerhouse fortified by extensive intellectual property moats in immunology, oncology, and neuroscience. The corporation owns major blockbuster pipelines including Skyrizi and Rinvoq—the designated successors to its historic multi-billion-dollar immunology anchor Humira—alongside the leading medical aesthetics franchise Botox, maintaining superior gross margins globally.